Last reviewed · How we verify

NCT04805190: SPAC

Study of Pain Catastrophizing-2 (SPAC-2)

Completed NA Last updated 14 May 2024
What this trial tests

NA trial testing Cognitive-Behavioral Intervention in Osteoarthritis, Knee in 99 participants. Completed in 12 December 2023.

Timeline
15 October 2021
Primary endpoint
12 December 2023
12 December 2023

Quick facts

Lead sponsorUniversity of Florida
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment99
Start date15 October 2021
Primary completion12 December 2023
Estimated completion12 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Florida

Who can join

Adults 45 to 85, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study experimentally manipulates pain catastrophizing in order to investigate the neural mechanisms by which pain catastrophizing influences the experience of pain in different ethnic groups among adults with knee osteoarthritis. Participants will be randomized to either a single session cognitive-behavioral intervention to reduce pain catastrophizing or a pain education control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cognitive-Behavioral Intervention

Trials testing the same drug.

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other University of Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04805190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing